Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$32.4 - $68.18 $52,196 - $109,837
1,611 Added 3.58%
46,558 $3.17 Million
Q2 2022

Aug 04, 2022

BUY
$22.3 - $37.39 $31,108 - $52,159
1,395 Added 3.2%
44,947 $1.44 Million
Q1 2022

May 05, 2022

BUY
$25.68 - $35.59 $12,377 - $17,154
482 Added 1.12%
43,552 $1.51 Million
Q4 2021

Feb 02, 2022

SELL
$24.9 - $40.26 $3,585 - $5,797
-144 Reduced 0.33%
43,070 $1.26 Million
Q3 2021

Nov 02, 2021

SELL
$25.48 - $37.34 $213,675 - $313,133
-8,386 Reduced 16.25%
43,214 $1.1 Million
Q2 2021

Aug 02, 2021

SELL
$32.46 - $43.42 $428,472 - $573,144
-13,200 Reduced 20.37%
51,600 $1.81 Million
Q1 2021

May 11, 2021

SELL
$38.94 - $50.85 $428,340 - $559,350
-11,000 Reduced 14.51%
64,800 $2.64 Million
Q4 2020

Feb 08, 2021

SELL
$37.65 - $63.77 $656,088 - $1.11 Million
-17,426 Reduced 18.69%
75,800 $3.28 Million
Q3 2020

Nov 05, 2020

BUY
$52.76 - $74.49 $31,656 - $44,694
600 Added 0.65%
93,226 $5.14 Million
Q2 2020

Aug 07, 2020

BUY
$48.73 - $81.82 $1.58 Million - $2.66 Million
32,467 Added 53.97%
92,626 $5.85 Million
Q1 2020

May 06, 2020

SELL
$41.72 - $87.2 $41,010 - $85,717
-983 Reduced 1.61%
60,159 $3.07 Million
Q4 2019

Feb 05, 2020

SELL
$45.7 - $81.86 $218,674 - $391,700
-4,785 Reduced 7.26%
61,142 $4.86 Million
Q3 2019

Nov 07, 2019

BUY
$45.35 - $57.91 $20,815 - $26,580
459 Added 0.7%
65,927 $3.2 Million
Q2 2019

Aug 09, 2019

BUY
$52.6 - $63.29 $236,700 - $284,805
4,500 Added 7.38%
65,468 $3.44 Million
Q1 2019

May 08, 2019

BUY
$39.99 - $53.48 $478,600 - $640,048
11,968 Added 24.42%
60,968 $3.23 Million
Q4 2018

Feb 08, 2019

SELL
$31.54 - $46.67 $393,556 - $582,348
-12,478 Reduced 20.3%
49,000 $2.01 Million
Q2 2018

Aug 10, 2018

BUY
$38.7 - $50.15 $530,964 - $688,058
13,720 Added 28.73%
61,478 $2.78 Million
Q1 2018

May 10, 2018

BUY
$39.6 - $65.9 $79,200 - $131,800
2,000 Added 4.37%
47,758 $2.31 Million
Q4 2017

Feb 13, 2018

BUY
$29.7 - $45.7 $185,862 - $285,990
6,258 Added 15.84%
45,758 $1.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
39,500
39,500 $1.08 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.